AR210937A1 - Procedimiento para la preparacion de la forma alfa cristalina de clorhidrato de 2-(4-(2-furoil)piperazin-1-il)-4-amino-6,7-dimetoxiquinazolina - Google Patents

Procedimiento para la preparacion de la forma alfa cristalina de clorhidrato de 2-(4-(2-furoil)piperazin-1-il)-4-amino-6,7-dimetoxiquinazolina

Info

Publication number
AR210937A1
AR210937A1 AR266724A AR26672477A AR210937A1 AR 210937 A1 AR210937 A1 AR 210937A1 AR 266724 A AR266724 A AR 266724A AR 26672477 A AR26672477 A AR 26672477A AR 210937 A1 AR210937 A1 AR 210937A1
Authority
AR
Argentina
Prior art keywords
dimetoxiquinazolina
furoil
crystaline
piperazin
alpha
Prior art date
Application number
AR266724A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR210937A1 publication Critical patent/AR210937A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
AR266724A 1976-03-01 1977-03-01 Procedimiento para la preparacion de la forma alfa cristalina de clorhidrato de 2-(4-(2-furoil)piperazin-1-il)-4-amino-6,7-dimetoxiquinazolina AR210937A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/662,937 US4092315A (en) 1976-03-01 1976-03-01 Novel crystalline forms of prazosin hydrochloride

Publications (1)

Publication Number Publication Date
AR210937A1 true AR210937A1 (es) 1977-09-30

Family

ID=24659839

Family Applications (1)

Application Number Title Priority Date Filing Date
AR266724A AR210937A1 (es) 1976-03-01 1977-03-01 Procedimiento para la preparacion de la forma alfa cristalina de clorhidrato de 2-(4-(2-furoil)piperazin-1-il)-4-amino-6,7-dimetoxiquinazolina

Country Status (32)

Country Link
US (1) US4092315A (es)
JP (1) JPS604188B2 (es)
AR (1) AR210937A1 (es)
AU (1) AU506937B2 (es)
BE (1) BE851878A (es)
BG (1) BG29724A3 (es)
CA (1) CA1068269A (es)
CH (1) CH618436A5 (es)
CS (1) CS191332B2 (es)
DD (1) DD129652A5 (es)
DE (1) DE2708192C3 (es)
DK (1) DK145858C (es)
ES (1) ES8707447A1 (es)
FI (1) FI62082C (es)
FR (1) FR2372828A1 (es)
GB (1) GB1538713A (es)
HK (1) HK30881A (es)
HU (1) HU173641B (es)
IE (1) IE44522B1 (es)
IL (1) IL51481A (es)
LU (1) LU76868A1 (es)
MY (1) MY8100271A (es)
NL (1) NL169591C (es)
NO (1) NO146499C (es)
NZ (1) NZ183450A (es)
PL (1) PL105559B1 (es)
PT (1) PT66227B (es)
RO (1) RO73095A (es)
SE (1) SE423234B (es)
SU (1) SU644387A3 (es)
YU (1) YU41294B (es)
ZA (1) ZA77918B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
MX5483E (es) * 1977-08-04 1983-08-23 Abbott Lab Procedimiento para la preparacion del dihidrato clorhidrato de 1-(4-amino-6,7-dimetoxi-2-quinazolinil)-4-(2-tetrahidrofuroil)piperazina
US4197301A (en) * 1978-10-16 1980-04-08 Allergan Pharmaceuticals, Inc. Topical ophthalmic use of Prazosin
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
US4440769A (en) * 1983-02-11 1984-04-03 Abbott Laboratories 2-(4-Phenylalkanoylpiperazin-1-yl) quinazoline compounds, pharmaceutical compositions and method of producing α1 antagonistic activity
FI79107C (fi) * 1984-06-25 1989-11-10 Orion Yhtymae Oy Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.
US5322943A (en) * 1985-09-12 1994-06-21 The Upjohn Company Piperazine compounds which are substituted
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation
ATE72244T1 (de) * 1986-03-21 1992-02-15 Heumann Pharma Gmbh & Co Kristalline, wasserfreie sigma -form von 2-(4-(2furoyl-(2-piperazin)-1-yl>-4-amino-6,7- dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
US5110927A (en) * 1987-12-31 1992-05-05 The United States Of America As Represented By The Department Of Health And Human Services Prazosin analog with increased selectivity and duration of action
JP2652272B2 (ja) * 1990-12-31 1997-09-10 住化ファインケム株式会社 １−（４−アミノ−６，７−ジメトキシ−２−キナゾリニル）−４−（２−テトラヒドロフロイル）ピペラジン塩酸塩の新規な結晶体および該結晶体の製造方法
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US5952003A (en) * 1996-08-01 1999-09-14 Novartis Corporation Terazosin capsules
EP0849264A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von doxazosinmesylat (Form I)
ATE353892T1 (de) * 1996-12-20 2007-03-15 Heumann Pharma Gmbh & Co Neue polymorphe form von doxazosinmesylat (form iii)
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
TR201818824T4 (tr) 2014-07-21 2019-01-21 Keir Mfg Inc Aerodinamik büküm çemberi.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663706A (en) * 1969-09-29 1972-05-16 Pfizer Use of 2,4-diaminoquinazolines as hypotensive agents

Also Published As

Publication number Publication date
NZ183450A (en) 1979-03-16
BE851878A (fr) 1977-08-29
JPS604188B2 (ja) 1985-02-01
FR2372828A1 (fr) 1978-06-30
ZA77918B (en) 1977-12-28
SE7701624L (sv) 1977-09-02
PT66227B (en) 1978-07-14
DD129652A5 (de) 1978-02-01
RO73095A (ro) 1981-06-26
HU173641B (en) 1979-07-28
FI770634A (es) 1977-09-02
IL51481A0 (en) 1977-04-29
NL169591C (nl) 1982-08-02
ES545368A0 (es) 1978-06-01
CH618436A5 (es) 1980-07-31
NL7702123A (nl) 1977-09-05
CS191332B2 (en) 1979-06-29
US4092315A (en) 1978-05-30
IE44522L (en) 1977-09-01
MY8100271A (en) 1981-12-31
FR2372828B1 (es) 1980-02-01
YU49977A (en) 1983-12-31
GB1538713A (en) 1979-01-24
ES8707447A1 (es) 1987-08-16
IE44522B1 (en) 1981-12-30
DK86877A (da) 1977-09-02
JPS52105206A (en) 1977-09-03
NL169591B (nl) 1982-03-01
YU41294B (en) 1987-02-28
DK145858B (da) 1983-03-21
FI62082C (fi) 1982-11-10
DE2708192C3 (de) 1980-05-08
DE2708192A1 (de) 1977-09-08
SU644387A3 (ru) 1979-01-25
PL105559B1 (pl) 1979-10-31
AU2244377A (en) 1978-11-23
PT66227A (en) 1977-03-01
LU76868A1 (es) 1977-09-21
NO146499B (no) 1982-07-05
FI62082B (fi) 1982-07-30
IL51481A (en) 1980-09-16
DK145858C (da) 1983-09-12
NO770674L (no) 1977-09-02
DE2708192B2 (de) 1979-08-02
NO146499C (no) 1982-10-13
BG29724A3 (en) 1981-01-15
AU506937B2 (en) 1980-01-31
PL196354A1 (pl) 1978-02-27
SE423234B (sv) 1982-04-26
HK30881A (en) 1981-07-10
CA1068269A (en) 1979-12-18

Similar Documents

Publication Publication Date Title
AR220525A1 (es) Procedimiento para obtener nuevos derivados de n-(2-mercapto,2-alcanoiltio,2-mercapto-alquil,2-alquiltio-alquiltio o2-alcanoiltioalquil)-acetil-prolina
AR224008A1 (es) Procedimiento para preparar polihidro-3,7-dimetil-8-(2-(tetrahidro-4-hidroxi-6-oxo-2h-piran-2-il)-etil)-1-naftil-2-metilbutirato
AR210937A1 (es) Procedimiento para la preparacion de la forma alfa cristalina de clorhidrato de 2-(4-(2-furoil)piperazin-1-il)-4-amino-6,7-dimetoxiquinazolina
MX6600E (es) Procedimiento para preparar 2,3-diariltiofenos 5-sustituidos
AR220689A1 (es) Procedimiento para obtener compuestos de n-(2-mercapto,2-benzoiltio,2-alcanoiltio-2-mercapto o 2-alquil)-acetil-tiazolidin o tiazancarboxilicos y sus sales
AR220129A1 (es) Procedimiento para la desnitrosacion de n-(1-etilpropil)-n-nitroso-2,6-dinitro-3,4-xilidina
AR207869A1 (es) Procedimiento para la produccion de nuevos derivados de 2-(4-alquil-1-piperacinil)-metil-1-bencil-benzimidazol
AR218242A1 (es) Procedimiento para la produccion de derivados de acidos n-(2-(imidazolil o tiazolil-metil-tio)-etil)-amidino formico
AR219173A1 (es) Procedimiento para la preparacion de 4-(2-hidroxi-3-(amino)propoxi)-2-bencimidazolinonas
AR213659A1 (es) Procedimiento para la preparacion de 2-(4-(aroil o heteroaroil)-piperazin-1-il)-4-amino-6,7-dimetoxiquinazolinas
AR219727A1 (es) Procedimiento para obtener fenil nonatetraeno sustituido
AR218247A1 (es) Procedimiento para la obtencion de derivados de 1-(2-aminoetil)-3-(2,6-dihalofenil)-tiourea
AR220126A1 (es) Procedimiento para la preparacion de 1,2,4-benzotiadiazina-1 oxido 3-amino-1-sustituido
AR218251A1 (es) Procedimiento para preparar 2-(4-(2-furoil)piperazin-1-il)4-amino-6,7-dimetoxi-quinazolina e intermediarios utilizados en el mismo
AR226705A1 (es) Procedimiento para preparar 1-acil-8-(3-amino-o 3-sustituido-amino-2 hidro-propoxi)-1-,2,3,4-tetrahidroquinolinas
MX5101E (es) Procedimiento para la preparacion de 2-(2',2',2',-trihalogenoetil)-4-halogenociclobutan-1-onas
MX5100E (es) Procedimiento para la produccion de 2-(2',2',-dihalovinil)-ciclobutanonas y 2-(2',2',2',-trihaloetil)-ciclobutanonas
AR210628A1 (es) Procedimiento para preparar 1,1-dioxidos de n-aril-2-metil-4-hidroxi-2h-1,2-benzotiazin-3-carboxamida
AR202999A1 (es) Procedimiento para la preparacion de 1,4-ioxido de 2-(2oxazolin-2-il)-3-metilquinoxalina
BE852348A (fr) 2-(2-acetamido-2-deoxy-3-0-d-glucopyranosyl)-d-propionyl-l-seryl-d-isoglutamine
ES493649A0 (es) Procedimiento para la fabricacion de 4-tiazolidonas,2-subs- tituidas
AR206624A1 (es) Procedimiento para la preparacion de derivados de 1,2,6,7-tetrahidro-2-metil-1-(2-(metil o etil)-aminoetil)-indolo-(1,7-ab)(1)benzacepina
ES492005A0 (es) Procedimiento mejorado para la preparacion de n-(2-amino-3,5-dibromobencil)-n-metilciclohexilamina
MX150444A (es) Procedimiento mejorado para la manufactura de articulos de friccion
MX3539E (es) Procedimiento para la paeparacion de 1-metil-2-(fenil-oximetil)-5-nitro-imidazoles